Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

2cureX: Individualizing Cancer Treatment

2020-08-31

07:20

OB

LS

Oscar Bergman

Ludvig Svensson

Redeye initiates coverage of 2cureX, a diagnostics company set to commercialize its precision test for colorectal cancer drugs. IndiTreat’s enabling of targeted individual treatment, with potential positive clinical trial results in Q1 2021, lays the ground for substantial future sales. Although the share has soared lately, the case still offers additional upside in the short to medium term.

Disclosures and disclaimers